Certified by Founder Lodge
Sixty Degree Capital
Canada - Toronto, Ontario
INVESTOR
1 Disclosed Funding Rounds $43,200,000
5 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Built on strength and balance, Sixty Degree Capital invests in the evolving areas of biopharmaceuticals, healthcare platforms and technology. Engaging with companies throughout North America,
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 05 ,2022 | Series B | $43,200,000.00 |
| Company | Date | Round | Raised |
|---|---|---|---|
Bionaut Labs |
December, 05 ,2022 | Series B | $43,200,000 |
DataGrail |
October, 13 ,2022 | Series C | $45,000,000 |
NextPoint Therapeutics, Inc. |
February, 15 ,2024 | Series B | $42,500,000 |
FogPharma |
March, 05 ,2024 | Series E | $145,000,000 |
Empirical Security |
July, 18 ,2025 | Seed | $12,000,000 |
Bionaut Labs
DataGrail
NextPoint Therapeutics, Inc.
FogPharma
Empirical Security
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)